IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $775,000 | +40.9% | 16,700 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $550,000 | -40.0% | 16,700 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $916,000 | -63.7% | 33,400 | -60.3% | 0.00% | -66.7% |
| Q1 2020 | $2,520,000 | +232.0% | 84,200 | -1.9% | 0.01% | +100.0% |
| Q4 2018 | $759,000 | -34.6% | 85,795 | -16.9% | 0.00% | -25.0% |
| Q3 2018 | $1,161,000 | -12.1% | 103,195 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $1,321,000 | -7.7% | 103,195 | +21.8% | 0.01% | -16.7% |
| Q1 2018 | $1,431,000 | -73.3% | 84,703 | -87.3% | 0.01% | -71.4% |
| Q4 2017 | $5,352,000 | +3.1% | 668,975 | -0.1% | 0.02% | -4.5% |
| Q3 2017 | $5,189,000 | +4.0% | 669,587 | -1.4% | 0.02% | -4.3% |
| Q2 2017 | $4,989,000 | – | 678,767 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |